• Home
  • Search Results

Search Results

Open
Young Adult (18-34)
338 studies match your search
Open

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Have you been diagnosed with metastatic breast cancer? If so, you may be able to take part in a research study looking at the efficacy of giving a drug called enzalutamide, alone or combined with mifepristone vs standard chemotherapy.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

A Phase 3 Study of DB-1303 vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Posit

Have you been diagnosed with metastatic breast cancer? If so, you may be able to take part in a research study looking at the safety and efficacy of giving a new drug called DB-1303 vs standard chemotherapy to patients with metastatic breast cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Diabetes study for patients with diabetes and renal impairment who are currently using basal insulin with or without Metformin or SGLT2 inhibitors

We are seeking participants with type 2 diabetes who use insulin and whose diabetes has affected kidney function and are interested in trying out a new medication that is expected to improve blood sugar control and prevent the weight gain (or induce weight loss) associated with increased insulin use. Compensation for time and travel are provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Diabetes
  • Kidneys and Liver
Open

UNC Food Allergy Registry

Looking for help with your food allergies? If so, you should join the Food Allergy Initiative (FAI) Registry! We are searching for people with food allergies who want to hear about new research studies. Signing up does not mean you have to join any studies or change the care you receive. It just means you will hear about research opportunities. You are welcome to decline at any time.

Age & Gender
  • 0 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
Visit Location
100% Remote (online, phone, text)
Open

Tobacco Health Message Eye Tracking Study

Do you smoke tobacco products? Participate in an eye-tracking research study and receive a $100 visa gift card.

Age & Gender
  • 21 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Healthy Volunteer or General Population
  • Opinions and Perceptions
  • Substance Use (tobacco, alcohol, opioids, etc)
Visit Location
Open

DFHCC-23-429: Glofitamab with or without polatuzumab vedotin or atezolizumab for Richter's Transformation

Have you been diagnosed with Chronic Lymphocytic Leukemia (CLL) that has transformed to aggressive lymphoma called Richter's Transformation (RT)? Then you may be able to participate in this study whose purpose is to evaluate the efficacy and safety of glofitamab as monotherapy and in combination with polatuzumab vedotin or atezolizumab for participants with Richter's Transformation (RT) that has transformed from chronic lymphocytic leukemia (CLL).

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia, Lymphoma)
Open

Depression Study Medication Trial

Are you experiencing symptoms of depression that have not been relieved by prescribed anti-depressant medication? If you have taken one or more prescribed anti-depressants and are still feeling symptoms of low mood, anxiety, sleep disruption, or appetite changes, you may be able to take part in a new medication trial for people who have not found other anti-depressants to help them. Compensation will be provided.

Age & Gender
  • 18 years ~ 65 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Mental and Emotional Health
  • Women's Health
  • Men's Health
Open

Study of Camizestrant in ER Positive, HER2 Negative, Early-Stage High Risk Breast Cancer.

Have you been diagnosed with breast cancer and completed your surgery? Has your doctor recommended hormonal therapy to help prevent your cancer from returning? You may be able to participate in a research study of a new drug called Camizestrant. Please reach out to the research team if you are interested and we will provide information regarding the next steps.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Study of CAR-T cells in patients with recurrent epithelial ovarian, peritoneal, or fallopian tube cancer

Do you have ovarian, peritoneal, or fallopian tube cancer that came back after receiving standard therapy? If so, you might be able to take part in a study that looks at a new treatment, iC9.CAR.B7-H3 cells, to test the safety of these cells and observe any side effects.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Ovarian)
Open

Families in Addiction Recovery Study

Do you want to share your journey of overcoming addiction and nurturing a positive environment for your child? We are listening. If you are a mother in recovery with a child aged 6-12, you may be able to participate in a study that helps families facing similar challenges. Compensation and childcare will be provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Parents of Children
  • Substance Use (tobacco, alcohol, opioids, etc)
Visit Location
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research